Monday June 26th 2017

Positive Results Announced from Phase 3 Study of Oral BG-12

/About-the-Society/News/Positive-Results-Announced-from-Phase-3-Study-of-O

Continue reading – 

Positive Results Announced from Phase 3 Study of Oral BG-12

Leave a Comment

More from category

Germany’s Merck gets EU backing for oral MS drug
Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…
New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation
MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill
MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Best multiple sclerosis blogs
Best multiple sclerosis blogs

Multiple sclerosis blogs are both helpful and inspirational for people affected by the disease. We have selected the 10 [Read More]